Patients with immunological diseases or on peritoneal dialysis are prone to false positive flow cytometry crossmatch.

[1]  K. Tinckam,et al.  Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff. , 2019, Hepatobiliary surgery and nutrition.

[2]  J. Friedewald,et al.  Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  N. K. Brown,et al.  Reanalysis of the role of pronase treatment of B cells in the flow cytometric crossmatch assay: Fc receptor is not the primary target. , 2017, Human immunology.

[4]  R. Bray,et al.  Becoming a chef in the human leukocyte antigen kitchen: interpretation and modification of human leukocyte antigen–antibody assays , 2017, Current opinion in organ transplantation.

[5]  R. Bray,et al.  It's about time: The development and validation of a rapid optimized single antigen bead (ROB) assay protocol for LABScreen. , 2017, Human immunology.

[6]  K. Barrios,et al.  Flow cytometry crossmatch reactivity with pronase-treated T cells induced by non-HLA autoantibodies in human immunodeficiency virus-infected patients. , 2016, Human immunology.

[7]  P. Nickerson,et al.  cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  L. Rostaing,et al.  Interference of therapeutic antibodies used in desensitization protocols on lymphocytotoxicity crossmatch results. , 2015, Transplant immunology.

[9]  B. Julian,et al.  New Insights into the Pathogenesis of IgA Nephropathy , 2015, Kidney Diseases.

[10]  C. Lutz,et al.  Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report. , 2015, Transplantation proceedings.

[11]  H. Hara,et al.  Acidic stress-ER stress axis for blunted activation of NF-κB in mesothelial cells exposed to peritoneal dialysis fluid. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  Dong-feng Chen,et al.  Pronase Treatment Interfering with T Cell Crossmatch: 2403 , 2012 .

[13]  P. Nickerson,et al.  30-OR: CANADA-WIDE EVALUATION OF RAPID OPTIMIZED FLOW CROSSMATCH (ROFCXM) PROTOCOL , 2012 .

[14]  B. Julian,et al.  The pathophysiology of IgA nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[15]  A. Ender,et al.  HLA Antibody Specification Using Single-Antigen Beads—A Technical Solution for the Prozone Effect , 2011, Transplantation.

[16]  A. Zachary,et al.  Impact of pronase on flow cytometric crossmatch outcome. , 2011, Human immunology.

[17]  F. Meloni,et al.  Effects of different peritoneal dialysis fluids on the TH1/TH2 balance. , 2011, European cytokine network.

[18]  D. Heinrichs,et al.  Receptor-Interacting Protein-2 Deficiency Delays Macrophage Migration and Increases Intracellular Infection during Peritoneal Dialysis-Associated Peritonitis , 2008, American Journal of Nephrology.

[19]  B. Wagner,et al.  Elevated B-cell autoantibodies among HIV+ transplant candidates: crossmatch implications. , 2005, Transplantation proceedings.

[20]  M. Pescovitz,et al.  New crossmatch technique eliminates interference by humanized and chimeric monoclonal antibodies. , 2005, Transplantation proceedings.

[21]  P. Nickerson,et al.  Pre‐Transplant Assessment of Donor‐Reactive, HLA‐Specific Antibodies in Renal Transplantation: Contraindication vs. Risk , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  A. Puig-Kröger,et al.  Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte‐derived dendritic cells: effect of lactate and glucose‐degradation products , 2003, Journal of leukocyte biology.

[23]  P. Nickerson,et al.  Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. , 2001, Journal of the American Society of Nephrology : JASN.

[24]  R. Bray,et al.  IMPROVED FLOW CYTOMETRIC DETECTION OF HLA ALLOANTIBODIES USING PRONASE: Potential Implications in Renal Transplantation , 2001, Transplantation.

[25]  M. Girndt,et al.  T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  S. Cohen,et al.  The frequency of Th2 type cells increases with time on peritoneal dialysis in patients with diabetic nephropathy. , 1999, European cytokine network.

[27]  T. Pruett,et al.  The use of pronase‐digested human leukocytes to improve specificity of the flow cytometric crossmatch , 1995 .

[28]  L. Lebeck,et al.  The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities. , 1989, Transplantation.

[29]  P. Terasaki,et al.  Significance of the positive crossmatch test in kidney transplantation. , 1969, The New England journal of medicine.

[30]  H. Gebel,et al.  Of Cells and Microparticles: Assets and Liabilities of HLA Antibody Detection. , 2018, Transplantation.

[31]  M. H. Park,et al.  Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests. , 2012, Transplantation proceedings.

[32]  J. Friedewald,et al.  Perception Versus Reality?: Virtual Crossmatch—How to Overcome Some of the Technical and Logistic Limitations , 2009 .